Effects of Acute Pain vs Context Change on Motor Learning Retention in Young Adults

Sponsor
University of Delaware (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05626582
Collaborator
(none)
50
3
10.4

Study Details

Study Description

Brief Summary

To date, the effects of pain on motor learning have not been thoroughly investigated. When examining potential effects on retention of motor learning, it is important to dissociate any effects of pain from effects of a context change. The purpose of this research is to determine whether any altered retention of motor learning associated with acute pain is a true affect of pain or an affect of context (or both).

Condition or Disease Intervention/Treatment Phase
  • Procedure: pain delivery - learning only
  • Procedure: pain delivery - learning and retention
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Masking Description:
Application of pain or no stimulus cannot be masked from participants, nor from outcomes assessors.
Primary Purpose:
Basic Science
Official Title:
Effects of Acute Pain vs Context Change on Motor Learning Retention in Young Adults
Anticipated Study Start Date :
Feb 1, 2023
Anticipated Primary Completion Date :
Dec 15, 2023
Anticipated Study Completion Date :
Dec 15, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Pain Stimulus - Learning Only

Capsaicin combined with heat applied to intact skin

Procedure: pain delivery - learning only
Experimental pain paradigm delivered (capsaicin cream combined with heat) that is short-term and painful but not harmful. Applied to skin just during the Day 1 learning period.

Experimental: Pain Stimulus - Learning and Retention

Capsaicin combined with heat applied to intact skin

Procedure: pain delivery - learning and retention
Experimental pain paradigm delivered (capsaicin cream combined with heat) that is short-term and painful but not harmful. Applied to skin during the Day 1 learning period and again during the Day 2 retention period.

No Intervention: No Stimulus

Nothing applied to skin

Outcome Measures

Primary Outcome Measures

  1. Motor Retention Magnitude [24 hours post learning (day 2)]

    degree to which the learned locomotor pattern has been remembered (in step length percent change, normalized to the amount learned from day 1)

  2. Motor Learning Magnitude [immediately after learning (day 1)]

    degree to which the new locomotor pattern has been acquired (in step length percent change)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 35 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes

Abbreviations: HR= heart rate, bpm= beats per minute; BP= blood pressure; ADD= attention deficit disorder; ADHD= attention deficit hyperactivity disorder; MoCA= Montreal Cognitive Assessment; GAD-7= Generalized Anxiety Disorder 7 Scale; PHQ-2, PHQ-9= Patient Health Questionnaire-2 and -9.

Inclusion Criteria:
  • 18-35 years old

  • Self-identifying as generally medically healthy

  • Able to read, write and speak English

  • Able to provide informed consent

  • Willing to undergo the experimental pain or non-painful electrical stimulation, if selected

Exclusion Criteria:
  • Resting HR < 50 or > 100 bpm

  • Resting BP < 90/60 or > 140/95 mmHg

  • Any history or current mental health condition, learning/developmental disability or cognitive impairment, including ADD/ADHD, severe anxiety, severe depression, autism spectrum disorder, insomnia, mild cognitive impairment, etc.

  • Score on the MoCA <23

  • Score on the GAD-7 ≥ 10

  • Score on the PHQ-2 ≥ 2 and score on the PHQ-9 ≥ 10

  • Any current (within last 3 month) or chronic medical conditions, including any musculoskeletal, cardiovascular, endocrine, pulmonary, metabolic, psychiatric or neurological diagnosis

  • Any implanted electronic medical devices (i.e., cardiac pacemakers, cardiac defibrillators, spinal cord neurostimulators)

  • Any impaired sensation or weakness in either lower extremity or in the area targeted for the stimulus

  • History of serious concussion or head injury, defined as a loss of consciousness for > 5 minutes and/or requiring medical treatment, or > 2 concussions over the lifespan

  • Any history of acute or chronic problems with balance, any dizziness, or > 1 fall in the last 12 months

  • Taking 4 or more medications

  • Currently or regularly using any analgesic medications, over-the-counter remedies, or any other treatment for the purposes of pain relief (i.e., baby aspirin for heart health permitted, etc.)

  • Any current or chronic pain condition during the last year, located anywhere in the body

  • Allergy to capsaicin or hot peppers

  • Any skin lesion, breakage or irritation in the area targeted for the painful stimulus

  • Skin sensitivity to soaps/creams/perfumes or to heat

  • Poor circulation in the area targeted for the painful stimulus

  • Prior participation in a locomotor learning study in this lab within the last 2 years

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • University of Delaware

Investigators

  • Principal Investigator: Susanne M Morton, PhD, University of Delaware

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Susanne M Morton, Associate Professor, University of Delaware
ClinicalTrials.gov Identifier:
NCT05626582
Other Study ID Numbers:
  • 1786370-1.3
First Posted:
Nov 23, 2022
Last Update Posted:
Dec 14, 2022
Last Verified:
Dec 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Susanne M Morton, Associate Professor, University of Delaware
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 14, 2022